Product Information

DEXTROAMP-AMPHET ER 5 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4661 per EA under NDC 42858005501. Its NADAC has been published 350 times since Oct 16, 2019.

The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Low Outlier
DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

42858005501

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210651

On Market Since

8/22/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has been published 350 times since Oct 16, 2019, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4661 per EA
All-time high$1.7654 (Jul 15, 2020)
All-time low$0.3459 (Apr 17, 2024)
52-week high$0.6684
52-week low$0.4032
Median price$0.6204
Average price$0.7404
Largest weekly change+62.9% (Oct 18, 2023)
Weeks tracked350
Tracking sinceOct 16, 2019

Price History

1W

0.0%

1M

-1.2%

3M

-1.6%

6M

+11.0%

1Y

-30.3%

3Y

-22.6%

5Y

-47.2%

All

-65.8%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 5 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 5 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $0.4661 per EA (NDC 42858005501), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHET ER 5 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has declined 65.8%. It has been tracked across 350 weekly CMS publications since Oct 16, 2019.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 5 MG CAP?

Since Oct 16, 2019, the NADAC for DEXTROAMP-AMPHET ER 5 MG CAP has ranged from a low of $0.3459 (Apr 17, 2024) to a high of $1.7654 (Jul 15, 2020), with a median of $0.6204 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 5 MG CAP?

2 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHET ER 5 MG CAP, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 5 MG CAP?

DEXTROAMP-AMPHET ER 5 MG CAP (NDC 42858005501) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.